The Use of Exenatide in Islet Transplant Recipients With Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic Effects
Transplantation - United States
doi 10.1097/tp.0b013e31817c4ab3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)